We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$33.8B
AUM Growth
+$4.19B
Cap. Flow
+$264M
Cap. Flow %
0.78%
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$52.4M
2
TSLA icon
Tesla
TSLA
+$42.1M
3
MSFT icon
Microsoft
MSFT
+$16.9M
4
DIS icon
Walt Disney
DIS
+$14.5M
5
MS icon
Morgan Stanley
MS
+$11.9M

Top Sells

Rank Stock Value
1
UN
Unilever NV New York Registry Shares
UN
+$48.8M
2
T icon
AT&T
T
+$25.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$20M
4
AMZN icon
Amazon
AMZN
+$15.7M
5
BIIB icon
Biogen
BIIB
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 13.6%
3 Healthcare 13.1%
4 Consumer Discretionary 11.54%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRD
2376
DELISTED
RR Donnelley & Sons Co.
RRD
$109K ﹤0.01%
48,293
+1,802
+4% +$2.71K
OIS icon
2377
Oil States International
OIS
$497M
$108K ﹤0.01%
21,591
+111
+0.5% +$430
TCRT icon
2378
Alaunos Therapeutics
TCRT
$4.96M
$104K ﹤0.01%
274
+90
+49% +$35.8K
PBYI icon
2379
Puma Biotechnology
PBYI
$422M
$103K ﹤0.01%
10,068
-5,971
-37% -$60.5K
KALA icon
2380
KALA BIO
KALA
$13.9M
$100K ﹤0.01%
6
+2
+50% +$37.6K
PTNR
2381
DELISTED
Partner Communications
PTNR
$97K ﹤0.01%
18,045
-584
-3% -$2.68K
QEP
2382
DELISTED
QEP RESOURCES, INC.
QEP
$97K ﹤0.01%
40,693
-30,051
-42% -$44.5K
GSH
2383
DELISTED
Guangshen Railway Co. Ltd
GSH
$93K ﹤0.01%
10,315
-3,247
-24% -$28.4K
CLVS
2384
DELISTED
Clovis Oncology, Inc.
CLVS
$91K ﹤0.01%
18,924
-32,087
-63% -$162K
CPLG
2385
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$88K ﹤0.01%
12,832
-1,648
-11% -$10K
BDSI
2386
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$88K ﹤0.01%
20,877
-6,448
-24% -$24.8K
FARM
2387
DELISTED
Farmer Brothers
FARM
$84K ﹤0.01%
18,075
-3,822
-17% -$16.4K
VYGR icon
2388
Voyager Therapeutics
VYGR
$184M
$81K ﹤0.01%
11,266
-1,539
-12% -$14.8K
ASMB icon
2389
Assembly Biosciences
ASMB
$497M
$80K ﹤0.01%
1,110
-157
-12% -$18.4K
ACGN
2390
DELISTED
Aceragen Inc
ACGN
$77K ﹤0.01%
1,243
AUD
2391
DELISTED
Audacy, Inc.
AUD
$77K ﹤0.01%
31,025
+5,809
+23% +$11.9K
EGIO
2392
DELISTED
Edgio, Inc. Common Stock
EGIO
$76K ﹤0.01%
+477
New +$87.2K
CALA
2393
DELISTED
Calithera Biosciences, Inc
CALA
$76K ﹤0.01%
+777
New +$68.1K
GERN icon
2394
Geron
GERN
$924M
$75K ﹤0.01%
47,377
+29,117
+159% +$53K
ARDX icon
2395
Ardelyx
ARDX
$1.26B
$74K ﹤0.01%
+11,401
New +$67.7K
SNR
2396
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$73K ﹤0.01%
+14,151
New +$69.1K
CRK icon
2397
Comstock Resources
CRK
$3.79B
$69K ﹤0.01%
15,715
-7,228
-32% -$35.8K
SXC icon
2398
SunCoke Energy
SXC
$709M
$67K ﹤0.01%
+15,516
New +$64.9K
HMHC
2399
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$67K ﹤0.01%
+20,092
New +$59.8K
TXMD icon
2400
TherapeuticsMD
TXMD
$24.4M
$65K ﹤0.01%
1,077
+19
+2% +$1.3K

Similar funds

Aperio Group's Q4 2020 Portfolio in Review

As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
  • Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
  • Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
  • Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
  • Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
  • Aperio Group opened 104 new positions and closed 53 in Q4 2020.
  • Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.